RDITX | TLLRX | RDITX / TLLRX | |
Total Expense Ratio | 0.72 | 0.35 | 206% |
Annual Report Gross Expense Ratio | 0.72 | 0.43 | 167% |
Fund Existence | 18 years | 16 years | - |
Gain YTD | 11.208 | 10.498 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 37.8B | 8.07B | 469% |
Annual Yield % from dividends | 0.91 | 1.78 | 51% |
Returns for 1 year | 13.18 | 14.43 | 91% |
Returns for 3 years | 41.99 | 51.64 | 81% |
Returns for 5 years | 47.49 | 73.40 | 65% |
Returns for 10 years | 82.43 | 132.22 | 62% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
YMAG | 15.32 | 0.15 | +0.99% |
YieldMax Magnificent 7 Fd Of Opt IncETFs | |||
INMU | 23.40 | 0.01 | +0.04% |
iShares Intermediate Muni Income Act ETF | |||
FTXH | 26.31 | N/A | +0.01% |
First Trust Nasdaq Pharmaceuticals ETF | |||
HYBX | 30.54 | -0.01 | -0.05% |
TCW High Yield Bond ETF | |||
BKAG | 41.89 | -0.09 | -0.21% |
BNY Mellon Core Bond ETF |